Metraipolis › archive › dc_7693f60a4d39
Empagliflozin-pirfenidone dual therapy improves cardiac function and structure in a preclinical two-hit HFpEF model — Europe PMC PMID:42318351
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42318351
- DOI
- 10.3389/fphar.2026.1781866
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T18:49:02.180Z
- SHA-256 of the archived text
fe06aa7058aac548c10937c9513043c73bfad8537806f3f46d242fa9a9f103a0- Stable URL of this page
https://metraipolis.com/documento/dc_7693f60a4d39
How to cite
Empagliflozin-pirfenidone dual therapy improves cardiac function and structure in a preclinical two-hit HFpEF model — Europe PMC PMID:42318351 — Europe PMC (en), https://europepmc.org/article/MED/42318351 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7693f60a4d39 (Metraipolis archive dc_7693f60a4d39, sha256 fe06aa7058aac548c10937c9513043c73bfad8537806f3f46d242fa9a9f103a0)
BibTeX
@misc{dc7693f60a4d39,
title = {Empagliflozin-pirfenidone dual therapy improves cardiac function and structure in a preclinical two-hit HFpEF model — Europe PMC PMID:42318351},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42318351},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7693f60a4d39; sha256 fe06aa7058aac548c10937c9513043c73bfad8537806f3f46d242fa9a9f103a0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42318351. Agents can read the archived copy with the MCP tool read_document.